Alkem Laboratories Limited — Others, 13-06-2025: Disclosure under SEBI Takeover Regulations

Samprada and Nanhamati Singh Family Trust has sold 0.67% of its shares in Alkem Laboratories, reducing its stake from 19.41% to 18.74%. The sale proceeds were distributed among the Trust’s beneficiaries. This slight stake reduction by a key shareholder could subtly impact the company’s ownership pattern and investor sentiment.